XML 38 R26.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2025
Stockholders’ Equity (Deficit) [Abstract]  
Schedule of Stock Options Awards Activity

The Company recognized stock-based compensation expense during the three months ended March 31, 2025 and 2024, as follows: 

 

   Three months ended
March,
 
   2025   2024 
Performance-based restricted stock awards  $
-
   $55,983 
Service-based restricted stock awards   2,100,504    6,180,528 
Option expense*   
-
    (1,335,027)
Total stock-based compensation  $2,100,504   $4,901,484 

 

* The option expense for the three months ended March 31, 2024, contains a reversal of stock-based compensation expenses from 2023 for cancelled option awards.
Schedule of Performance-Based Restricted Stock Awards Activity

The following table presents a summary of the Company’s performance-based restricted stock awards activity:

 

   Number
of shares
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Outstanding as of December 31, 2024   72,101    7.56 
Exercised   
-
    
-
 
Expired/forfeited   
-
    
-
 
Outstanding as of March 31, 2025   72,101    7.31 
Exercisable as of March 31, 2025   72,101    7.31 

The following table presents a summary of the Company’s service-based awards activity:

 

   Number of
shares
   Weighted
Average
Remaining
Contractual
Life
(in years)
 
Outstanding as of December 31, 2024   14,178,458    1.30 
Issued   1,235,030    
-
 
Forfeited/cancelled   (72,047)   
-
 
Outstanding as of March 31, 2025   15,341,441    0.99 
Exercisable as of March 31, 2025   1,921,566    0.01 
Schedule of Stock Options Awards Activity

The following table presents a summary of the Company’s Stock options awards activity:

 

   Number of
shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
(in years)
   Aggregate
Intrinsic
Value
 
Outstanding as of December 31, 2024   3,500,417   $1.07    9.20   $
-
 
Issued   
-
    
-
    -    
-
 
Outstanding as of March 31, 2025   3,500,417   $1.07    8.95   $
-
 
Exercisable as of March 31, 2025   3,500,417   $1.07    -   $
-